ELAN Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Elanco Animal Health Incorporated (NYSE: ELAN) Investors with Significant Losses to Contact the Firm

RADNOR, Pa.--(BUSINESS WIRE)--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Elanco Animal Health Incorporated (NYSE: ELAN) (“Elanco”).

On June 27, 2024, Elanco issued a press release providing updates to the company’s expected FDA approval timelines for its animal disease treatments, Zenrelia and Credelio Quattro. In the release, Elanco stated that Zenrelia is expected to receive FDA approval in the third quarter of 2024, leading to a potential commercial launch in the fourth quarter of 2024, despite the company having previously set a launch timeline for the third quarter of 2024. Elanco also stated that Credelio Quattro is expected to receive FDA approval in the fourth quarter of 2024, despite having previously set an approval timeline for the third quarter of 2024.

On this news, Elanco's stock price fell $3.69 per share, or 20.53%, to close at $14.28 per share on June 27, 2024.

If you are an Elanco investor and would like to learn more about our investigation, please CLICK HERE to fill out our online form or contact Kessler Topaz Meltzer & Check, LLP: Jonathan Naji, Esq. [phone] or E-mail at [e-mail]. You can also click on the following link or paste it in your browser: https://www.ktmc.com/elanco-animal-health-incorporated-investigation?utm_source=PR&utm_medium=link&utm_campaign=elan&mktm=r

Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law. Kessler Topaz Meltzer & Check, LLP is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars). For more information Kessler Topaz Meltzer & Check, LLP, please visit www.ktmc.com.

May be considered attorney advertising in certain jurisdictions. Past results do not guarantee future outcomes.